11/12
02:21 pm
vygr
Voyager Therapeutics (NASDAQ:VYGR) had its price target lowered by analysts at HC Wainwright from $30.00 to $25.00. They now have a "buy" rating on the stock.
Low
Report
Voyager Therapeutics (NASDAQ:VYGR) had its price target lowered by analysts at HC Wainwright from $30.00 to $25.00. They now have a "buy" rating on the stock.
11/11
10:08 am
vygr
Voyager Therapeutics (NASDAQ:VYGR) had its "outperform" rating reaffirmed by analysts at Wedbush. They now have a $8.00 price target on the stock.
Medium
Report
Voyager Therapeutics (NASDAQ:VYGR) had its "outperform" rating reaffirmed by analysts at Wedbush. They now have a $8.00 price target on the stock.
11/10
08:40 am
vygr
Voyager Reports Third Quarter 2025 Financial and Operating Results [Yahoo! Finance]
Low
Report
Voyager Reports Third Quarter 2025 Financial and Operating Results [Yahoo! Finance]
11/10
08:40 am
vygr
Transition Bio and Voyager Announce Collaboration to Advance Small Molecules Targeting TDP-43 in ALS and Frontotemporal Dementia [Yahoo! Finance]
Low
Report
Transition Bio and Voyager Announce Collaboration to Advance Small Molecules Targeting TDP-43 in ALS and Frontotemporal Dementia [Yahoo! Finance]
11/10
08:01 am
vygr
Transition Bio and Voyager Announce Collaboration to Advance Small Molecules Targeting TDP-43 in ALS and Frontotemporal Dementia
Medium
Report
Transition Bio and Voyager Announce Collaboration to Advance Small Molecules Targeting TDP-43 in ALS and Frontotemporal Dementia
11/10
08:01 am
vygr
Voyager Reports Third Quarter 2025 Financial and Operating Results
Medium
Report
Voyager Reports Third Quarter 2025 Financial and Operating Results
10/1
07:25 am
vygr
AIRNA Appoints Allison Dorval as Chief Financial Officer and Niru Subramanian as Chief Operating Officer [Yahoo! Finance]
Low
Report
AIRNA Appoints Allison Dorval as Chief Financial Officer and Niru Subramanian as Chief Operating Officer [Yahoo! Finance]
9/18
08:05 pm
vygr
A new biotech venture firm emerges, led by Bob Langer's son [Yahoo! Finance]
Medium
Report
A new biotech venture firm emerges, led by Bob Langer's son [Yahoo! Finance]
9/15
02:15 pm
vygr
Voyager Therapeutics Alzheimer's Portfolio And ALPL NeuroShuttle Underscore Platform Momentum: Analyst [Yahoo! Finance]
Low
Report
Voyager Therapeutics Alzheimer's Portfolio And ALPL NeuroShuttle Underscore Platform Momentum: Analyst [Yahoo! Finance]
9/15
08:06 am
vygr
Voyager Therapeutics (NASDAQ:VYGR) had its "buy" rating reaffirmed by analysts at HC Wainwright. They now have a $30.00 price target on the stock.
Low
Report
Voyager Therapeutics (NASDAQ:VYGR) had its "buy" rating reaffirmed by analysts at HC Wainwright. They now have a $30.00 price target on the stock.